Impact of Project Wolbachia - Singapore on Dengue Incidence
NCT05505682 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 724428
Last updated 2025-05-22
Summary
The study is a cluster-randomised controlled trial set in Singapore, to assess if the deployment of male Wolbachia-infected Aedes aegypti mosquitoes can reduce dengue incidence in intervention clusters.
Conditions
- Dengue
Interventions
- BIOLOGICAL
-
Biological (Male Wolbachia-infected Aedes aegypti)
Releases of male Wolbachia-infected Aedes aegypti mosquitoes
Sponsors & Collaborators
-
Ministry of Health, Singapore
collaborator OTHER_GOV -
National Environment Agency, Singapore
lead OTHER_GOV
Principal Investigators
-
Lee Ching Ng, PhD · Group Director (Environmental Health Institute)
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-07-28
- Primary Completion
- 2024-09-13
- Completion
- 2024-09-13
Countries
- Singapore
Study Locations
More Related Trials
-
Dengue Vaccine Hesitancy and Acceptance in Endemic Regions of Argentina: Impact of Communication Strategies
NCT05213364 ·Status: UNKNOWN
-
Sustainable Reduction of Dengue in Colombia: Vector Breeding Site Intervention With an Insecticidal Coating
NCT06268691 ·Status: COMPLETED ·Phase: NA
-
World Mosquito Program Noumea - Human Sample Component
NCT03552094 ·Status: UNKNOWN
-
Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in Singapore
NCT02569827 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Investigating Vector-Borne Determinants of Aedes Transmitted Arboviral Infections in Cambodia: An Observational Longitudinal Cohort Study in Children
NCT03534245 ·Status: COMPLETED
-
Genetic Evolution of Arboviruses in New Caledonia Between 1995 and 2024 and Impact of Wolbachia
NCT04615364 ·Status: RECRUITING
-
Immuno-epidemiological and Socio-behavioral Evaluation of Release of Sterile Male Aedes Albopictus Mosquitoes on Human-vector Contacts
NCT05313126 ·Status: UNKNOWN ·Phase: NA
-
A Study of Dengue Vaccine in Healthy Children, Teenagers and Adults in India
NCT06060067 ·Status: COMPLETED ·Phase: PHASE3
-
Virological and Immunological Determinants of Arbovirus Infection in New Caledonia
NCT04619823 ·Status: RECRUITING ·Phase: NA
-
Spatial Repellents for Aedes-borne Virus Control in Sri Lanka
NCT05452447 ·Status: COMPLETED ·Phase: NA
-
Safety Study of Dengushield in Healthy Adults
NCT03883620 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Safety and Immunogenicity of AGS-v PLUS, a Universal Mosquito-Borne Disease and Mosquito Control Vaccine
NCT04009824 ·Status: COMPLETED ·Phase: PHASE1
-
Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia
NCT01254422 ·Status: COMPLETED ·Phase: PHASE3
-
Sylvatic Transmission of Zika, Dengue, and Chikungunya Viruses in Thailand and Cambodia
NCT04434846 ·Status: COMPLETED
-
Safety and Immunogenicity of Direct Venous Inoculation of a Radiation-attenuated PfSPZ Vaccine in Equatoguinean Adults
NCT02418962 ·Status: COMPLETED ·Phase: PHASE1
-
Testing Combined IIT-SIT to Control Mosquito-Borne Diseases At Scale
NCT06595745 ·Status: TERMINATED ·Phase: NA
-
Attractive Targeted Sugar Bait Trial in Mali
NCT04149119 ·Status: UNKNOWN ·Phase: NA
-
Sero-epidemiology of Priority Arboviruses in French Guiana
NCT03210363 ·Status: COMPLETED ·Phase: NA
-
Spatial Repellents for Vector Control
NCT04795648 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity of a First-in-Human Mosquito Saliva Peptide Vaccine
NCT03055000 ·Status: COMPLETED ·Phase: PHASE1
-
Implementation Research of New Dengue Vector Control Tools
NCT00883441 ·Status: COMPLETED ·Phase: NA
-
Factors Associated With Hospitalization and Severity of Arbovirosis in the Indian Ocean
NCT07119086 ·Status: RECRUITING ·Phase: NA
-
Febrile Disease Landscape in Cambodia Via Metagenomic Pathogen Sequencing
NCT04034264 ·Status: RECRUITING
-
Safety and Causal Prophylactic Efficacy of KAF156 in a Controlled Human Malaria Challenge Model
NCT04072302 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity and Safety of Subunit Plague Vaccine
NCT02596308 ·Status: COMPLETED ·Phase: PHASE2